Trymex

ANDA 88198, held by Savage Labs. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 88198 (Trymex), held by Savage Labs, was first approved by FDA on Mar 25, 1983, with 5 approved supplements and 0 published complete response letters.

First approved: Mar 25, 1983
Supplements approved: 5
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 6 submissions below

Date	Submission	Status	Documents
Mar 25, 1983	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Trymex0.5% · cream;topical	Triamcinolone Acetonide	Discontinued

All 6 submissions, including labeling and manufacturing supplements


Mar 4, 1988	Supplement 6Manufacturing	Approved	None posted
Mar 4, 1988	Supplement 7Manufacturing	Approved	None posted
May 29, 1987	Supplement 4Manufacturing	Approved	None posted
Dec 3, 1986	Supplement 5Manufacturing	Approved	None posted
Jul 8, 1983	Supplement 2Manufacturing	Approved	None posted
Mar 25, 1983	Original application	Approved	None posted

Identifiers

Application: ANDA 88198
Drugs@FDA: Overview at FDA
Company: Savage Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters